Related Experiment Videos

Distinct roles of Jun : Fos and Jun : ATF dimers in oncogenesis

H van Dam1, M Castellazzi

  • 1Department of Molecular Cell Biology, Leiden University Medical Center, Sylvius Laboratories, PO Box 9503, 2300 RA Leiden, The Netherlands.

Oncogene
|June 13, 2001
PubMed

Insights

Jun:Fos and Jun:ATF dimers have distinct roles in oncogenesis. Jun:ATF2 dimers, not Jun:Fra2, trigger fibrosarcomas by repressing SPARC, highlighting their roles in cancer progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cellular Signaling

Background:

  • Activating Protein-1 (AP-1) dimers, including Jun:Fos and Jun:ATF complexes, bind distinct AP-1 sites.
  • These dimers are differentially regulated by cellular signaling and oncogenes, suggesting varied functional roles.

Purpose of the Study:

  • To differentiate the functions of Jun:Fos, Jun:ATF, and Jun:Jun dimers in oncogenesis.
  • To investigate the specific roles of Jun dimerization mutants in cellular transformation and tumor development.

Main Methods:

  • Development of Jun dimerization mutants to restrict specific dimerization partners (Jun:Jun, Jun:Fos, Jun:ATF).
  • Introduction of these mutants into chicken embryo fibroblasts to assess in vitro oncogenesis.
  • Analysis of tumor development in chicken wings and identification of target genes.

Main Results:

  • Jun:Fra2 and Jun:ATF2 dimers induce anchorage independence and growth factor independence, respectively.
  • v-Jun:ATF2, not v-Jun:Fra2, triggers primary fibrosarcoma development in chicken wings.
  • Extracellular matrix genes, including SPARC, are key targets of v-Jun:ATF2; SPARC repression is crucial for fibrosarcoma induction.

Conclusions:

  • Jun:Fos and Jun:ATF dimers play distinct, complementary roles in oncogenesis.
  • Jun:ATF2 dimers are critical for fibrosarcoma development, partly through repression of SPARC.
  • Avian cell systems with Jun dimerization mutants are valuable tools for studying oncogenesis pathways.

Related Concept Videos